Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jan 1;207(1):196-8.
doi: 10.1093/infdis/jis637. Epub 2012 Oct 22.

Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States

Kirk M Chan-Tack, Arlene Gao, Amalia C Himaya, Elizabeth G Thompson, Mary E Singer, Timothy M Uyeki, Debra B Birnkrant
Comment

Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States

Kirk M Chan-Tack et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Comment in

  • Reply to Chan-Tack et al.
    Fraaij PL, van der Vries E, Osterhaus AD. Fraaij PL, et al. J Infect Dis. 2013 Jan 1;207(1):198-9. doi: 10.1093/infdis/jis638. Epub 2012 Oct 22. J Infect Dis. 2013. PMID: 23089588 No abstract available.

Comment on

References

    1. Fraaij P, van der Vries E, Beersma M, et al. Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection. J Infect Dis 2011; 204:777–82. - PMC - PubMed
    1. Emergency use of an investigational new drug (IND). 21 CFR Sect 312. 36 (2009).
    1. Wijaya L, Chua YY, Cui L, et al. Intravenous zanamivir in critically ill patients due to pandemic 2009 H1N1 influenza A virus. Singapore Med J 2011; 52:481–5. - PubMed
    1. Gaur AH, Bigga B, Barman B, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010; 362:88–9. - PubMed
    1. Dulek DE, Williams JV, Creech CB, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis 2010; 50:1493–6. - PubMed

MeSH terms